Hereditary Angioedema: Enhancing Patient Quality of Life Through Individualized Treatment and Improved Access to Care

CE / CME

Hereditary Angioedema: Enhancing Patient Quality of Life Through Individualized Treatment and Improved Access to Care

Nurses/Nurse Practitioners: 1.00 NAPNAP contact hour, including 1.00 hour of pharmacotherapy credit

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Released: October 31, 2022

Expiration: December 15, 2023

Chrystal Lewis
Chrystal Lewis, PhD, RN
Marc Riedl
Marc Riedl, MD, MS
Susan Tiso
Susan Tiso, DNP, FNP-BC

Pretest

Progress
1 2
Course Completed
1.

Which of the following is an oral medication recommended first-line for long-term prophylaxis in patients with hereditary angioedema (HAE)?

2.

Which of these measures is the most helpful strategy to ensure successful transition to adult-oriented care?

3.

Which of the following is an effective way to improve access to care in rural settings?

4.

How often do you currently consider using long-term prophylaxis in patients with HAE?

5.

How often do you currently implement transition strategies when managing pediatric patients with HAE?

6.

How often do you currently address barriers to care to ensure access to necessary treatments for patient with HAE?